Use of ciprofloxacin in biliary sepsis

Ciprofloxacin is a new carboxylic acid derivative. It is active against gram-positive and gram-negative bacteria, with minimal inhibitory concentrations (MICs) generally around 0.01 mg/l. These favorable properties prompted the authors to study the efficacy and safety of ciprofloxacin in biliary sep...

Full description

Saved in:
Bibliographic Details
Published in:Infection 1988-07, Vol.16 (4), p.249-249
Main Authors: CHRYSANTHOPOULOS, C. J, SKOUTELIS, A. T, STARAKIS, J. C, ARVANITI, A, BASSARIS, H. P
Format: Article
Language:English
Subjects:
Adult
Aged
Antibacterial agents
Antibiotics. Antiinfectious agents. Antiparasitic agents
Bacterial Infections - drug therapy
Biliary Tract Diseases - drug therapy
Biological and medical sciences
Ciprofloxacin - therapeutic use
Female
Humans
Male
Medical sciences
Middle Aged
Pharmacology. Drug treatments
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Ciprofloxacin is a new carboxylic acid derivative. It is active against gram-positive and gram-negative bacteria, with minimal inhibitory concentrations (MICs) generally around 0.01 mg/l. These favorable properties prompted the authors to study the efficacy and safety of ciprofloxacin in biliary sepsis. Therapy was successful in 25 patients (including 18 with bacteremia), and failed in five patients.
ISSN:0300-8126
1439-0973
DOI:10.1007/BF01650766